Expanding the Promise of Immunotherapy

Leveraging elite immune responses to develop novel cancer immunotherapies


The Right People in the Right Place at the Right Time

Making advancements in immuno-oncology through strategic partnerships



November 7, 2017
OncoResponse Adds Anti-EMP2 Antibody to Oncology Pipeline Through Acquisition of Paganini Biopharma

April 4, 2017
OncoResponse to Present at BioCentury Future Leaders Conference